TY - JOUR
T1 - Pediatric chronic graft-versus-host disease-related dry eye disease and the diagnostic association of potential clinical findings
AU - Yagi, Hitomi
AU - Shimizu, Eisuke
AU - Yagi, Ryuichiro
AU - Uchino, Miki
AU - Kamoi, Mizuka
AU - Asai, Kazuki
AU - Tsubota, Kazuo
AU - Negishi, Kazuno
AU - Ogawa, Yoko
N1 - Funding Information:
We deeply appreciate the huge efforts and instructions on this study for Professor Takao Takahashi, Drs. Hiroyuki Shimada, Fumito Yamazaki, Haruko Shima, and Takumi Kurosawa at the Department of Pediatrics, Keio University School of Medicine. We are grateful to Drs. Yukako Tatematsu, Shinri Sato, and Yumiko Saijo at the dry eye subspecialty clinic of Keio University Hospital. We thank all orthoptists at the outpatient clinic of Keio University Hospital. This research was supported by a Japanese Ministry of Education, Science, Sports, and Culture grant to Y.O. (No. 26462668).
Funding Information:
We deeply appreciate the huge efforts and instructions on this study for Professor Takao Takahashi, Drs. Hiroyuki Shimada, Fumito Yamazaki, Haruko Shima, and Takumi Kurosawa at the Department of Pediatrics, Keio University School of Medicine. We are grateful to Drs. Yukako Tatematsu, Shinri Sato, and Yumiko Saijo at the dry eye subspecialty clinic of Keio University Hospital. We thank all orthoptists at the outpatient clinic of Keio University Hospital. This research was supported by a Japanese Ministry of Education, Science, Sports, and Culture grant to Y.O. (No. 26462668).
Funding Information:
K.T. has a patent with a patent (Patent No. JP6967260) and a patent (Patent No. JP6936496). Outside the submitted work, K.T. reports his position as CEO of Tsubota Laboratory, Inc., Tokyo, Japan, a company working on treatments, preventive agents, and medical devices for DED. Y.O. has a patent in Japan (Patent No. 4966019; Title: Topical application and oral intake of tranilast for the treatment of cGVHD-related dye eye disease). Y.O. and K.T. have patent application numbers JP 2017–018643, published as JPA2017-178922. Y.O., E. S., and K.T. have patent application numbers JP2018-510646 published as WO2017/175808. E.S. has a grant from the Japanese Ministry of Education, Science, Sports, and Culture 21K18394 and Bristol Myers Squibb. The other authors received no financial support or additional benefit from commercial sources for the work reported in this manuscript. Moreover, the authors have no financial interests that may create a potential conflict or the appearance of a conflict of interest regarding this work.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Pediatric graft-versus-host-disease (GVHD)-related dry eye disease (DED) is often overlooked due to a lack of subjective symptoms and reliable testing, leading to irreversible corneal damage. To study the clinical findings contributing to the accurate detection of pediatric GVHD-related DED, a retrospective study of pediatric patients treated with hematopoietic stem cell transplantation (HSCT) at Keio University Hospital between 2004 and 2017 was conducted. Association and diagnostic values of ophthalmological findings for DED were analyzed. Twenty-six patients who had no ocular complications before HSCT were included in the study. Eleven (42.3%) patients developed new-onset DED. The cotton thread test showed excellent diagnostic accuracy in detecting DED (area under the receiver operating curve, 0.96; sensitivity, 0.95; specificity, 0.85) with a cut-off of 17 mm, which was higher than the conventional threshold of 10 mm. Additionally, the presence of filamentary keratitis (FK) and pseudomembranous conjunctivitis (PC) were significantly associated with the diagnosis of DED (p value, 0.003 and 0.001 for FK and PC, respectively) and displayed good diagnostic performance (sensitivity, 0.46 and 0.54; specificity, 0.97 and 0.97 for FK and PC, respectively). In conclusion, the cotton thread test with a new threshold, the presence of PC and FK, could be helpful for promptly detecting pediatric GVHD-related DED.
AB - Pediatric graft-versus-host-disease (GVHD)-related dry eye disease (DED) is often overlooked due to a lack of subjective symptoms and reliable testing, leading to irreversible corneal damage. To study the clinical findings contributing to the accurate detection of pediatric GVHD-related DED, a retrospective study of pediatric patients treated with hematopoietic stem cell transplantation (HSCT) at Keio University Hospital between 2004 and 2017 was conducted. Association and diagnostic values of ophthalmological findings for DED were analyzed. Twenty-six patients who had no ocular complications before HSCT were included in the study. Eleven (42.3%) patients developed new-onset DED. The cotton thread test showed excellent diagnostic accuracy in detecting DED (area under the receiver operating curve, 0.96; sensitivity, 0.95; specificity, 0.85) with a cut-off of 17 mm, which was higher than the conventional threshold of 10 mm. Additionally, the presence of filamentary keratitis (FK) and pseudomembranous conjunctivitis (PC) were significantly associated with the diagnosis of DED (p value, 0.003 and 0.001 for FK and PC, respectively) and displayed good diagnostic performance (sensitivity, 0.46 and 0.54; specificity, 0.97 and 0.97 for FK and PC, respectively). In conclusion, the cotton thread test with a new threshold, the presence of PC and FK, could be helpful for promptly detecting pediatric GVHD-related DED.
UR - http://www.scopus.com/inward/record.url?scp=85149281690&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149281690&partnerID=8YFLogxK
U2 - 10.1038/s41598-023-30288-6
DO - 10.1038/s41598-023-30288-6
M3 - Article
C2 - 36864106
AN - SCOPUS:85149281690
SN - 2045-2322
VL - 13
JO - Scientific reports
JF - Scientific reports
IS - 1
M1 - 3575
ER -